Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study
- 1 October 2000
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (10) , 1303-1309
- https://doi.org/10.1046/j.1365-2036.2000.00841.x
Abstract
Background: Intestinal type metaplasia plays a role in intestinal type gastric carcinoma development. Ascorbic acid demonstrates a protective effect against gastric carcinogenesis, due to its abilit...Keywords
This publication has 34 references indexed in Scilit:
- Proliferative activity of gastric epithelium in progressive stages ofHelicobacter pylori infectionDigestive Diseases and Sciences, 1996
- Gastric Antioxidant, Nitrites, and Mucosal Lipoperoxidation in Chronic Gastritis and Helicobacter pylori InfectionJournal of Clinical Gastroenterology, 1996
- Helicobacter pylori in promotion of gastric carcinogenesisDigestive Diseases and Sciences, 1996
- Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma.Gut, 1996
- Helicobacter pylori in patients with intestinal metaplasia and in controlsEuropean Journal Of Cancer Prevention, 1995
- Helicobacter pylori infection and gastric juice vitamin C levelsDigestive Diseases and Sciences, 1995
- Prevalence of Intestinal Metaplasia inHelicobacter pyloriGastritisScandinavian Journal of Gastroenterology, 1994
- Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations.Gut, 1993
- Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori.Journal of Clinical Pathology, 1992
- Plasma vitamin concentrations in patients with intestinal metaplasia and in controlsEuropean Journal Of Cancer Prevention, 1992